Whole-body (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Demonstrating Multiple Rare Extracranial Metastases in a Treated Case of Glioblastoma

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults that accounts for nearly 20% of all primary malignant brain tumors. While GBM is notable for local recurrence and invasion, extracranial metastases (ECMs) are exceedingly rare, occurring in <2% of patients. However, the repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamaleshwaran, Koramadai Karuppusamy, Ramkumar, Elumalai, Raghunathan, Madhu Sairam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Interesting Image
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693363/
https://www.ncbi.nlm.nih.gov/pubmed/38046964
http://dx.doi.org/10.4103/ijnm.ijnm_167_22
Descripción
Sumario:Glioblastoma (GBM) is the most aggressive primary brain tumor in adults that accounts for nearly 20% of all primary malignant brain tumors. While GBM is notable for local recurrence and invasion, extracranial metastases (ECMs) are exceedingly rare, occurring in <2% of patients. However, the report of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) imaging in evaluating ECM is limited, and the importance of whole-body FDG PET/CT imaging in GBM has not been well elucidated. We present here a case of GBM, post excision 12 years before, whole-body (18)F-FDG PET/CT showing no recurrence in the brain and ECM to multiple bones, right kidney, and pancreas.

Ejemplares similares